FDA Inspection 1241811 — Vitalant
The FDA completed an inspection of Vitalant on June 11, 2024 in Santa Rosa, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 11, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Santa Rosa, CA (United States)